Sharmin Khan
- Oncology top 10%
- Hematology top 5%
- Molecular Biology
- Genetics top 10%
- Immunology
- Co-authors
- Shmuel YaccobyWen LingXin LiAngela PennisiBart BarlogieJohn D. ShaughnessyMaurizio ZangariRakesh Bam
- Topics
- Multiple Myeloma Research and Treatments (16 papers)Bone health and treatments (8 papers)Mesenchymal stem cell research (4 papers)
- Cited by
- HematologyGeneticsOncology
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- United StatesBangladeshDenmark
In The Last Decade
Sharmin Khan
25 papers receiving 511 citations
Peers
Comparison fields: 5 of 78
- Oncology 245
- Hematology 239
- Molecular Biology 224
- Genetics 105
- Immunology 50
Countries citing papers authored by Sharmin Khan
This map shows the geographic impact of Sharmin Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmin Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmin Khan more than expected).
Fields of papers citing papers by Sharmin Khan
This network shows the impact of papers produced by Sharmin Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmin Khan. The network helps show where Sharmin Khan may publish in the future.
Co-authorship network of co-authors of Sharmin Khan
This figure shows the co-authorship network connecting the top 25 collaborators of Sharmin Khan. A scholar is included among the top collaborators of Sharmin Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmin Khan. Sharmin Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 24 | |
| 7 | Understanding Customer Loyalty of M-Commerce Applications in Saudi Arabia | 11 |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 14 | |
| 11 | 2 | |
| 12 | 45 | |
| 13 | 8 | |
| 14 | 0 | |
| 15 | 3 | |
| 16 | 35 | |
| 17 | 0 | |
| 18 | 14 | |
| 19 | 79 | |
| 20 | 110 |
About Sharmin Khan
Sharmin Khan is a scholar working on Hematology, Genetics and Oncology, having authored 29 papers that have together received 519 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Bone health and treatments (8 papers) and Mesenchymal stem cell research (4 papers). The work is most often cited by research in Hematology (239 citations), Genetics (105 citations) and Oncology (245 citations). Sharmin Khan has collaborated with scholars based in United States, Bangladesh and Denmark. Frequent co-authors include Shmuel Yaccoby, Wen Ling, Xin Li, Angela Pennisi, Bart Barlogie, John D. Shaughnessy, Maurizio Zangari, Rakesh Bam, Joshua Epstein and Frits van Rhee. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.